Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-08-01FDA Approved: METOPROLOL SUCCINATE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved metoprolol succinate as a generic product through an original ANDA submission by Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS research · 2012-07-31Clinical Trial Update: Recurrent Stroke Prevention Clinical Outcome Study [Phase 4]
A Phase 4 clinical outcome study on recurrent stroke prevention sponsored by Biomedis International Ltd is underway, focusing on hypertensio…
-
FDA approval · 2012-07-27FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for benazepril hydrochloride and hydrochlorothiazide (Padagis US LLC).
-
FDA approval · 2012-07-26FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA granted supplemental approval for a fixed-dose combination product of amlodipine and atorvastatin by Prasco Laboratories. This appro…
-
FDA approval · 2012-07-26FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for DIOVAN HCT (valsartan and hydrochlorothiazide) from Novartis Pharmaceuticals Corporation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure [Phase 2]
Phase 2 pharmacodynamic study evaluating the effect of a fixed-dose combination antihypertensive pill on blood pressure in hypertensive pati…
-
EMA withdrawal · 2012-07-23EMA Withdrawn: Sprimeo (aliskiren) — Novartis Europharm Ltd.
EMA withdrew Sprimeo (aliskiren) from the European market.
-
FDA approval · 2012-07-20FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for losartan potassium submitted by Quallent Pharmaceuticals Health LLC under ANDA078243.
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study [Phase 4]
An update on a Phase 4 clinical trial comparing carvedilol to bisoprolol for central pulse pressure in hypertension; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Impact of Computerized Reminders on Blood Pressure Documentation and Control [Phase 1]
A Phase 1 clinical trial evaluating whether computerized reminders improve documentation and control of blood pressure in people with hypert…
-
CLINICAL_TRIALS withdrawal · 2012-07-16Clinical Trial Update: Does Administration of Etomidate and Propofol of the Anesthetic Induction of Elderly Hypertensive Patient Provide Superior Blood Pressure Stability in Response to Direct Laryngoscopy When Compared to Propofol or Etomidate Alone? [Phase 3]
A Phase 3 trial evaluating whether combining etomidate and propofol provides better blood pressure stability during direct laryngoscopy in e…
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: An Intervention to Improve Communication Between Physicians and Minority Patients With Hypertension [NA]
A completed study evaluating an intervention designed to improve communication between physicians and minority patients with hypertension.
-
FDA label_change · 2012-07-11FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for furosemide from Chartwell RX, LLC, resulting in changes to the drug's labeling.
-
FDA approval · 2012-07-10FDA Approved: LABETALOL HCL — Original Application (Par Health USA, LLC)
The FDA approved the original application for Labetalol hydrochloride (LABETALOL HCL) by Par Health USA, LLC as a generic product for the tr…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Effect of Pioglitazone on Ambulatory Blood Pressure [Phase 3]
Phase 3 clinical trial evaluating the effect of pioglitazone on ambulatory blood pressure in patients with hypertension and type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease [Phase 3]
Phase 3 trial investigating the role of aldosterone in hypertensive heart disease has completed, examining aldosterone’s involvement in the …
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients [Phase 4]
This update concerns a Phase 4 clinical trial comparing aliskiren and amlodipine in patients with hypertension who are on dialysis.
-
CLINICAL_TRIALS research · 2012-07-09Clinical Trial Update: RAAS Inhibitor Drugs in Dialysis Patients [Phase 4]
An ongoing Phase 4 trial evaluating RAAS inhibitor drugs in dialysis patients with hypertension and end-stage renal disease.
-
CLINICAL_TRIALS withdrawal · 2012-07-06Clinical Trial Update: Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients [Phase 4]
A Phase 4 trial evaluating eplerenone for elderly patients with hypertension and early-stage chronic kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-06Clinical Trial Update: Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating losartan on retinal endothelial function in patients with essential hypertension has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch [Phase 3]
Phase 3 trial evaluating a fixed-dose single-pill combination of telmisartan and amlodipine for hypertension has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Telmisartan 80mg Non-responder Trial [Phase 3]
A Phase 3 trial evaluating telmisartan 80 mg in hypertension non-responders has completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: The Effects of Polyphenol-rich Berry Juice on Blood Pressure in Hypertensive Subjects [Phase 3]
A Phase 3 trial evaluating the effects of polyphenol-rich berry juice on blood pressure in individuals with prehypertension or hypertension …
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg
This entry reports the completion and posting of results for the PRO-POWER trial evaluating telmisartan (Micardis) with or without hydrochlo…
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Treatment of Hypertension With Adalat® in Combination With Other Drugs
A completed clinical trial studying Adalat (nifedipine) in combination with other drugs for hypertension.